Galaxy10 reported on October 30th that Beijing Aosaikang Pharmaceutical (002755.SZ) released its third-quarter report. The company achieved revenue of 1.384 billion yuan in the first three quarters, a year-on-year increase of 23.64%; net income of 0.127 billion yuan, a year-on-year increase of 168.79%. In the third quarter alone, revenue reached 0.462 billion yuan, a year-on-year increase of 13.23%; net income was 51.4232 million yuan, a year-on-year increase of 296.25%.
奥赛康(002755.SZ)第三季度净利润同比增长296.25%
Beijing Aosaikang Pharmaceutical (002755.SZ) net income in the third quarter increased by 296.25% year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.